{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:16:47Z","timestamp":1789132607445,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Yale Center for Mendelian Genomics","award":["U54 HG006504"],"award-info":[{"award-number":["U54 HG006504"]}]},{"name":"George M. O\u2019Brien Kidney Center at Yale","award":["P30 DK079310"],"award-info":[{"award-number":["P30 DK079310"]}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1053\/j.ajkd.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T10:22:58Z","timestamp":1529662978000},"page":"895-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD\u2014A Novel Presentation"],"prefix":"10.1053","volume":"72","author":[{"given":"Ashima","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen E.","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Dykas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Bia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel M.","family":"Danovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert W.","family":"Moeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neera K.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.4081\/hr.2017.7053","article-title":"Atypical hemolytic uremic syndrome: a brief review","volume":"9","author":"Zhang","year":"2017","journal-title":"Hematol Rep"},{"issue":"9","key":"10.1053\/j.ajkd.2018.05.006_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ng2082","article-title":"C-terminal truncations in human 3\u2032-5\u2032 DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy","volume":"39","author":"Richards","year":"2007","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.ajkd.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/brain\/aww217","article-title":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","volume":"139","author":"Stam","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1053\/j.ajkd.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"issue":"19","key":"10.1053\/j.ajkd.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"14547","DOI":"10.1074\/jbc.M700236200","article-title":"Structure of the dimeric exonuclease TREX1 in complex with DNA displays a proline-rich binding site for WW domains","volume":"282","author":"Brucet","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1053\/j.ajkd.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/jth.13764","article-title":"Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics","volume":"15","author":"Saha","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"R2","key":"10.1053\/j.ajkd.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1093\/hmg\/ddp293","article-title":"Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity","volume":"18","author":"Crow","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1053\/j.ajkd.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1053\/j.ajkd.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1053\/j.ajkd.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat Genet"},{"issue":"5","key":"10.1053\/j.ajkd.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.49.5.1322","article-title":"Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS)","volume":"49","author":"Jen","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1053\/j.ajkd.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-9071.2005.00976.x","article-title":"Novel ophthalmological features in hereditary endotheliopathy with retinopathy, nephropathy and stroke syndrome","volume":"33","author":"Cohn","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/bpa.12178","article-title":"Neuropathology and genetics of cerebroretinal vasculopathies","volume":"24","author":"Kolar","year":"2014","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0161-6420(88)33131-3","article-title":"Cerebroretinal vasculopathy. A new hereditary syndrome","volume":"95","author":"Grand","year":"1988","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1053\/j.ajkd.2018.05.006_bib15","first-page":"77","article-title":"Hereditary systemic angiopathy (HSA) with cerebral calcifications, retinopathy, progressive nephropathy, and hepatopathy","volume":"255","author":"Winkler","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.24583","article-title":"A\u00a044-year-old man with eye, kidney, and brain dysfunction","volume":"79","author":"Vodopivec","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1053\/j.ajkd.2018.05.006_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167A","author":"Crow","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1053\/j.ajkd.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1212\/NXI.0000000000000055","article-title":"Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL","volume":"2","author":"Schuh","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1053\/j.ajkd.2018.05.006_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10072-014-1944-9","article-title":"TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy","volume":"36","author":"DiFrancesco","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1053\/j.ajkd.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-015-0588-3","article-title":"Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells","volume":"17","author":"Castellano","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"24","key":"10.1053\/j.ajkd.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ajkd.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","article-title":"Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies","volume":"120","author":"Fuchs","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ajkd.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.4049\/jimmunol.1401334","article-title":"Phenotypic variation in Aicardi-Gouti\u00e8res syndrome explained by cell-specific IFN-stimulated gene response and cytokine release","volume":"194","author":"Cuadrado","year":"2015","journal-title":"J\u00a0Immunol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618307017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618307017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:17:21Z","timestamp":1759461441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618307017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0272638618307017"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.05.006","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD\u2014A Novel Presentation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}